Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Even with FDA approval there is no way this stock could go to $1 per share due to the OS? Unless this became a billion dollar company or something? I mean I guess they have something in the pipeline to attempt to cure breast cancer.
An Reverse Split could make this stock go to a $1 but that would not benefit the stock investors I guess.
Conspiracy to prevent cure for cancer... And how this may affect BMSN/RGBP:
The War on Cancer...
The War on Cancer...
Last time I checked outstanding shares was 4.2 billion. With all the dilution and even with FDA approval. Could BMSN rise above $0.01/share?
Reverse Split could take it above $0.01 but that seems of no benefit to me.
Yes... I pointed out maybe not more then a penny for BMSN mainly due to it's outstanding shares.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116681593
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=116683577
With its outstanding shares in the billions, 4.2 billion. How high do you think a share could go?
The shares outstanding if I am correct for BMSN is 4.2 billion. Sorry if I am wasting anybodies time, but what is the potential of BMSN rising above 1 penny a share and why?
What reasons would BMSN do a reverse split?
These are questions... I am not fully educated in stocks, in like how they work. People or someone have claimed that BMSN is diluted and that it is a pump and dump. Some or whoever have agreed that BMSN was just a way to earn money from the shareholders to fund operations which I would assume naturally it would. But that BMSN diluted too much of its stock that it will not be worth much, so BMSN was maybe not in the long term investment in the interests of its shareholders because eventually due to dilution it would drop to low per share... BMSN may have never been in the interest of the shareholders. BMSN may have just about raising funds for operations.
I have just been trying to understand the dilution and have made efforts to compare other companies that seem of the same nature as BMSN that have OS in the billions (dilution?) cause most companies of the Bio Tech/medical or whatever from http://stemcellmeetingonthemesa.com/attendees/ do not or at least the companies I was able to find stocks on do not have shares in the billions for OS. This OS in relation to companies listed on http://stemcellmeetingonthemesa.com/attendees/ can be found below.
Any ways for you I am maybe going to ask stupid questions. So if these questions are stupid then I apologize to whatever extent necessary. As I don't want to waste peoples time. But I also question how valuable the information that is posted in this BMSN board and to what extent. Meaning maybe there are a lot of posts with no valuable information posted in reference to helping one determine whether to invest in BMSN or not.
This has to to do with OS/dilution in relation to BMSN and other Bio Tech's/ pharmaceutical/medical companies or whatever from http://stemcellmeetingonthemesa.com/attendees/ that I found in part via TD Ameritrade as a way of comparison and the ones with OS in the billions are set in bold as follows below. Not all the companies listed in the link above appeared to have stock so I looked for which ones I could find that did. The reason for this search/post is due to BMSN's considered dilution and its potential value in possible relevance/comparison to other companies of the same or possibly the same/similar nature as BMSN. I just wonder if BMSN can reach $0.10/share
BMSN Shares Outstanding 4.0B, Price $0.0005
Astellas Pharma Inc OTC Pink - Current Information: ALPMY, Shares Outstanding 2.2B, Closing Price $14.71
Asterias Biotherapeutics Inc Shares Outstanding 32.3M, Price $11.43
Athersys Inc NASDAQ: ATHX, Shares Outstanding 82.9M, Price $1.33
Avalanche Biotechnologies Inc NASDAQ: AAVL, Shares Outstanding 25.5M, Price $36.86
Avita Medical Ltd OTCQX International: AVMXY, Shares Outstanding 16.3M, Price $1.35
AxoGen Inc NASDAQ: AXGN, Shares Outstanding 24.9M, Price $3.03
Baxter International Inc NYSE: BAX, Shares Outstanding 544.3M, Price
$66.27
BioLife Solutions Inc NASDAQ: BLFS, Shares Outstanding 12.2M, Price $1.93
bluebird bio Inc NASDAQ: BLUE, Shares Outstanding 32.8M, Price $187.50
Capricor Therapeutics Inc NASDAQ: CAPR, Shares Outstanding 16.2M, Price
$6.00
Celgene Corp NASDAQ: CELG, Shares Outstanding 793.1M, Price $113.67
Celladon Corp NASDAQ: CLDN, Shares Outstanding 23.9M, Price $2.33
Cytori Therapeutics Inc NASDAQ: CYTX, Shares Outstanding 139.2M, Price
$0.6816
Fate Therapeutics Inc NASDAQ: FATE, Shares Outstanding 26.6M, Price
$5.94
Fibrocell Science Inc NASDAQ: FCSC, Shares Outstanding 40.9M, Price
$5.00
Merge Healthcare Inc NASDAQ: MRGE, Shares Outstanding 98.7M, Price
$4.52
Genfit SA OTC Pink - Current Information: GNFTF, Shares Outstanding 24.0M, Price $41.00
InVivo Therapeutics Holdings Corp NASDAQ: NVIV, Shares Outstanding 26.6M, Price $14.49
KaloBios Pharmaceuticals Inc NASDAQ: KBIO, Shares Outstanding 33.0M, Price $0.5774
Mesoblast Ltd OTC Pink - Current Information: MBLTY, Shares Outstanding 63.9M, Price $14.84
MiMedx Group Inc NASDAQ: MDXG, Shares Outstanding 108.6M, Price $10.20
NeoStem Inc NASDAQ: NBS, Shares Outstanding 51.9M, Price $2.23
Novartis AG NYSE: NVS, Shares Outstanding 2.4B, Price $103.27
NuTech Inc OTC Pink - No Information: NTCI, Shares Outstanding --, Price
$0.01
Organovo Holdings Inc NYSE MKT LLC: ONVO, Shares Outstanding 80.5M, Price $4.89
Osiris Therapeutics Inc NASDAQ: OSIR, Shares Outstanding 34.4M, Price
$18.75
Oxford BioMedica PLC Grey Market: OXBDF, Shares Outstanding 2.6B, Price $0.16
RepliCel Life Sciences Inc OTCQB: REPCF, Shares Outstanding 54.9M, Closing Price $0.30
Sangamo BioSciences Inc NASDAQ: SGMO, Shares Outstanding 69.6M, Closing Price $12.53
Smith & Nephew PLC NYSE: SNN, Shares Outstanding 447.2M, Closing Price
$35.28
Takeda Pharmaceutical Co Ltd OTC Pink - Current Information: TKPYY, Shares Outstanding 1.6B, Closing Price $24.23
Vertex Pharmaceuticals Inc NASDAQ: VRTX, Shares Outstanding 243.8M, Closing Price $124.80
Vital Therapies Inc NASDAQ: VTL, Shares Outstanding 24.0M, Closing Price
$21.49
The volume seems low for BMSN, especially when as it appears on TD Ameritrade there is 4.0 billion OS of BMSN. So, I guess this may mean whatever extent of people are expecting BMSN to run.
Thanks, but where is the proof?
So what kind of news is going to make this jump to at least $0.01/share?
Do you have an example? And why are you all ways bashing BMSN?
Any solid contributions that any one wants to post with valuable information for reasons to or not to invest further in BMSN stock?
Anybody got anything that they think may be considered valuable information in reference to investing in BMSN?
BMSN is just too diluted now, right? That it is not worth further investing in?
Can anyone pin point and knock this out... I wonder if anyone takes notes of BMSN from the time they showed interest in BMSN. Notes for evaluation of BMSN.
I wonder if Kendall Prince still owns those BMSN shares from that stock purchase agreement you provided... And if upon purchasing those shares if Kendall Prince discussed potential of BMSN stock in relations to dilution with Mr. Koos.
So outside of the agreement between Kendall Prince and Koos I guess. I wonder what Kendall Prince may expect BMSN share to reach based on possible conversations with Koos that possibly were not in the agreement but were maybe utilized as some sort of forecast.
I'm not sure if it bothered me. I was just wondering you did not use public response.
What is kendall prince supposed to mean any ways? How come you respond outside of public response to my posts? It seems you have for the most part or all the time.
I don't trust Koos, but I do not have enough to state why. And its mainly just based off a feeling from viewing him in a video. But the team seems more promising or maybe just Thomas Ichim the former CEO of Medistem.
In depth, what is BMSN potential once and if these products become developed and marketed: HemaXellerate I**, dCellVax™ and HemaXellerate II™. Further how much credit will Regen Take that in the development of these products above that in which may take value from future of BMSN shares. Below is list, a comparison of other companies of possible similarities to BMSN due in part to considered dilution. How similar are the companies below. Do these companies have more products than BMSN and what is it's worth of their products as well as what potential worth of potential products BMSN has in it's pipeline. Not sure if I should invest anymore in BMSN. I wonder if anybody out there has insight into the possibility of BMSN reaching $0.10/share.
Astellas Pharma Inc OTC Pink - Current Information: ALPMY, Shares Outstanding 2.2B, Closing Price $14.71. Here are what appear to be Astellas products: http://www.astellas.us/therapeutic/product/index.aspx
Novartis AG NYSE: NVS, Shares Outstanding 2.4B, Price $103.27. What appears to be Novartis AG products: http://www.novartis.com/products/index.shtml
Oxford BioMedica PLC Grey Market: OXBDF, Shares Outstanding 2.6B, Price $0.16. This appears to be their product list but note that to whatever extent these products actually have not yet been fully developed and are undergoing study so have not yet been marketed: http://www.oxfordbiomedica.co.uk/products/
Takeda Pharmaceutical Co Ltd OTC Pink - Current Information: TKPYY, Shares Outstanding 1.6B, Closing Price $24.23. What appears to be their products: http://www.takeda.com/products/
This has to to do with OS/dilution in relation to BMSN and other Bio Tech's/ pharmaceutical/medical companies or whatever from http://stemcellmeetingonthemesa.com/attendees/ that I found in part via TD Ameritrade as a way of comparison and the ones with OS in the billions are set in bold as follows below. Not all the companies listed in the link above appeared to have stock so I looked for which ones I could find that did. The reason for this search/post is due to BMSN's considered dilution and its potential value in possible relevance/comparison to other companies of the same or possibly the same/similar nature as BMSN. I just wonder if BMSN can reach $0.10/share
BMSN Shares Outstanding 4.0B, Price $0.0005
Astellas Pharma Inc OTC Pink - Current Information: ALPMY, Shares Outstanding 2.2B, Closing Price $14.71
Asterias Biotherapeutics Inc Shares Outstanding 32.3M, Price $11.43
Athersys Inc NASDAQ: ATHX, Shares Outstanding 82.9M, Price $1.33
Avalanche Biotechnologies Inc NASDAQ: AAVL, Shares Outstanding 25.5M, Price $36.86
Avita Medical Ltd OTCQX International: AVMXY, Shares Outstanding 16.3M, Price $1.35
AxoGen Inc NASDAQ: AXGN, Shares Outstanding 24.9M, Price $3.03
Baxter International Inc NYSE: BAX, Shares Outstanding 544.3M, Price
$66.27
BioLife Solutions Inc NASDAQ: BLFS, Shares Outstanding 12.2M, Price $1.93
bluebird bio Inc NASDAQ: BLUE, Shares Outstanding 32.8M, Price $187.50
Capricor Therapeutics Inc NASDAQ: CAPR, Shares Outstanding 16.2M, Price
$6.00
Celgene Corp NASDAQ: CELG, Shares Outstanding 793.1M, Price $113.67
Celladon Corp NASDAQ: CLDN, Shares Outstanding 23.9M, Price $2.33
Cytori Therapeutics Inc NASDAQ: CYTX, Shares Outstanding 139.2M, Price
$0.6816
Fate Therapeutics Inc NASDAQ: FATE, Shares Outstanding 26.6M, Price
$5.94
Fibrocell Science Inc NASDAQ: FCSC, Shares Outstanding 40.9M, Price
$5.00
Merge Healthcare Inc NASDAQ: MRGE, Shares Outstanding 98.7M, Price
$4.52
Genfit SA OTC Pink - Current Information: GNFTF, Shares Outstanding 24.0M, Price $41.00
InVivo Therapeutics Holdings Corp NASDAQ: NVIV, Shares Outstanding 26.6M, Price $14.49
KaloBios Pharmaceuticals Inc NASDAQ: KBIO, Shares Outstanding 33.0M, Price $0.5774
Mesoblast Ltd OTC Pink - Current Information: MBLTY, Shares Outstanding 63.9M, Price $14.84
MiMedx Group Inc NASDAQ: MDXG, Shares Outstanding 108.6M, Price $10.20
NeoStem Inc NASDAQ: NBS, Shares Outstanding 51.9M, Price $2.23
Novartis AG NYSE: NVS, Shares Outstanding 2.4B, Price $103.27
NuTech Inc OTC Pink - No Information: NTCI, Shares Outstanding --, Price
$0.01
Organovo Holdings Inc NYSE MKT LLC: ONVO, Shares Outstanding 80.5M, Price $4.89
Osiris Therapeutics Inc NASDAQ: OSIR, Shares Outstanding 34.4M, Price
$18.75
Oxford BioMedica PLC Grey Market: OXBDF, Shares Outstanding 2.6B, Price $0.16
RepliCel Life Sciences Inc OTCQB: REPCF, Shares Outstanding 54.9M, Closing Price $0.30
Sangamo BioSciences Inc NASDAQ: SGMO, Shares Outstanding 69.6M, Closing Price $12.53
Smith & Nephew PLC NYSE: SNN, Shares Outstanding 447.2M, Closing Price
$35.28
Takeda Pharmaceutical Co Ltd OTC Pink - Current Information: TKPYY, Shares Outstanding 1.6B, Closing Price $24.23
Vertex Pharmaceuticals Inc NASDAQ: VRTX, Shares Outstanding 243.8M, Closing Price $124.80
Vital Therapies Inc NASDAQ: VTL, Shares Outstanding 24.0M, Closing Price
$21.49
Sorry, anyone know what Astellas Pharma, Inc (ALPMY) OS is?
Potential I meant for BMSN. I'll try to check out other bio tech stem cell companies to see how much OS they have and there share price...
In regards to comparison your maybe right. But I just used Apple Inc. due to its popularity in comparison to BMSN in reference to BMSN dilution to value BMSN potential value per share. I mean BMSN has more OS then Apple INC.
I have researched other Bio Techs stocks and also companies if I am correct from http://stemcellmeetingonthemesa.com/ who meet to discuss there bio technology company plans in relation to stem cells and BMSN was on this list however many times for whatever years.
Every stem cell company that was on this list for like 2013, 2014 or something that had their stock on the market was at least $1/share or more except BMSN which I thought was actually related to potential.
Sorry if I am all dumb or something but where I am staying at has mold and I need to move out this week.
undervalue?
I don't know. I am questioning BMSN's potential value in regards to how much dilution of BMSN stock there is.
I'm not sure if it can reach $0.10/share even with developed bio technology that is marketed, maybe it might depend upon how much different bio technology they may produce that may become marketed.
Maybe this is more legit but still Apple. Inc has less OS than BMSN according to this:
http://appleinsider.com/articles/14/06/06/apple-increases-issued-shares-for-7-for-1-stock-split-in-official-sec-amendment
With BMSN OS at OS 3,079,910,118 as of 09/24/14 if accurate what do you think the potential of BMSN share may reach with a bio technology developed and marketed? And according to this if BMSN OS above is correct it dropped to 2,951,013,321 a/o Jan 29, 2014 http://www.otcmarkets.com/stock/BMSN/profile
I'm not sure I understand? I thought I meant that BMSN has more OS than AAPL based on that link http://www.streetinsider.com/stock_lookup.php?cik=320193&financials=balance&chartkeyid=31 if that link is correct.
Yeah, that is true I guess last time I checked the CEO did owe a bunch of the stock in my opinion I guess. And if I read correctly, BMSN stock was also given to whatever employees of BMSN. Pump and Dump or not, BMSN has too much dilution? BMSN has more OS then Apple INC. if this is correct... http://www.streetinsider.com/stock_lookup.php?cik=320193&financials=balance&chartkeyid=31
I forgot that Koos does own a bunch BMSN stock... You would think then that if Koos does still owns that amount of stock the indications of how much it is projected that will be worth in the future in comparison to the amount that the shareholders own as well?...
Sorry if I am all retarded right now.
Regen and BMSN are or for the most part the same people. This website I think used to be called Bio Matrix Scientific Group http://www.regenbiopharma.com/ or Bio Matrix Scientific Group used to have a website until possibly Regen website came along.
Regen was maybe just created to raise funds for Regen/BMSN operations and BMSN was possibly just a pump and dump.
Who would if it hurts that BMSN transferred all its ownership over to Regen.
What is the purpose now in having BMSN and Regen when they are or for the most part the same people. Is BMSN really necessary at this point since it may just be extra paper work for whatever people in BMSN and Regen?
BMSN projects are the same as Regen and Regen maybe has more products....
I would not know how to do the proper estimation of potential price for a BMSN share in these circumstances. I just don't know where it can go with that much dilution. BMSN may end after and if HemaXellerate I™ is developed unless BMSN just sells it...
With all the dilution of BMSN I am not sure if this could reach eventually $0.10/share and I don't know how these shares would convert to another company that may buy out BMSN if BMSN was bought such as Pfizer.
I believe questions are good for investigation to help one determine whether to invest in a stock.
Shouldn't the posts on whatever this is be like an intelligence community that provides legitimate resources and info in regards to the stock people are interested in. That may also consist of debate among the people who posts that may result in answers about BMSN operations...
Why not ask questions? I think I do ask not too much and this forum/board whatever it is in reference to posts on BMSN seems dead. A lot of posts here on BMSN... seem to not have any in depth resources in reference to what they post. How does a lot of the posts on this board help one determine if not one should invest. Maybe there is not enough questions and answers on this board as well as possibly to whatever extent lack of resources in reference to what people post on investorhub about BMSN.
Chances BMSN buys back its own stock? What if BMSN does develop a Bio Technology that is marketable and then gets bought by an existing company such as possibly Pfizer then BMSN stock would convert over to Pfizer???
Wondering because if it is possible for BMSN to go into the penny land.
So I guess BMSN has more OS stocks than Apple Inc.
http://www.streetinsider.com/stock_lookup.php?cik=320193&financials=balance&chartkeyid=31
All though I do not see 2015 for Apple Inc. and this is just one resources meaning I would want more than one resource to confirm possibly depending on my perceived credibility of the resource.
BMSN was just a pump and dump? To fuel their operations from investors which later resulted in RGBP? So BMSN even with FDA approval and if they do establish a bio technology there is too much dilution for BMSN to go up into at least a penny per share?
Plus, since RGBP and BMSN are working on the same product all though RGBP is subsidiary of BMSN. Who will take credit for bio technologies they both may be working on or how is it distributed.
It seems like Regen has good patents to become potential bio technology. But BMSN was just a pump and dump so it is unlikely for it shares to go into the penny land due to dilution?
Bio-Matrix Scientific Group, Inc. and Subsidiary (Formerly Tasco International, Inc.)? http://www.sec.gov/Archives/edgar/data/1079282/000115752307001591/a5335070.htm
Thomas Ichim seems legit to an extent but I do not trust Koos as much for some reason...
Since whatever extent RGBP is a subsidiary of BMSN. And appears BMSN/RGBP are working on the same things except Cancer Treatment via siRNA and Innate Immune System Stimulation.
I just wonder who will take credit for joint projects and how Each share may be worth.
BMSN had around 30 patents out of 2000 or something they selected/acquired.
I plan on holding to an extent BMSN shares until it reaches $1.00/share.
The only thing as of now is clinical trials to begin and it is not clear whether the FDA has approved of it or not.
Common Sense, are you sure that exists in this world. Maybe so.
Any ways what is sp and pr? Bio Pharma companies might not communicate with another companies invitation for communication if they have no interests in the company which maybe if they see the company as not useful for whatever reasons.
I don't know if you had to rub that in my face like that even it was a dumb and or stupid question.
Do you have any web links that verify this:
"Also, while hemaxellerate is out of our hands rgbp/bmsn is in discussions with BP and sp for partnerships, leasing of patents, etc"?
What does RGBP/BMSN have going for it and its investors...?
Okay, so RGBP/BMSN based on research to whatever extent seems to consist of good news in developing all though people are questioning the time, and some might argue the quality in relations to the development of RGBP/BMSN.
I just wonder if RGBP/BMSN has any competing technologies? If it's patents are considered cutting edge or something of remarkable technology then what implications may one draw about this? To what extent is RGBP/BMSN acting alone to develop these patents into existing technology prior to possibly selling this potential technology under development or marketing this patented technology?
If they have some type of remarkable patented technology that is in development then what drug companies or whatever companies may be watching such as possibly Pfizer?
Further I wonder if the FDA has a priority on what companies to deal with first or at all in regards to allowing tests, clinical trials... If the FDA is working with BMSN to whatever extent to possibly allow tests and clinical trials then this may mean that the FDA knows BMSN has a potential technology that is of use to humankind ($$$?). So possibly the FDA has placed whatever type of priority on BMSN in relations to when and how the FDA deals with RGBP/BMSN in comparison to other bio tech companies.
BMSN may be trying to establish itself or I guess Regen or both as an independent companys without help of whatever extent from other companies thus rendering independence some how which could relate to money being made by BMSN/REGEN. All though it appears they have business partners (this does not necessarily mean it impedes upon BMSN/Regen independence...).
In regards to investors of BMSN in reference to shares if all these investors are directly linked to BMSN from purchasing it's stock at whatever extent.
Does BMSN have too much dilution that it could never rise to $1.00/share?
I wonder in relations to BMSN and Regen who will take credit for possibly developed Bio Technologies? Since it seems to whatever extent they are working on the same projects.
I anticipate for BMSN to reach at least $1/share in the future.
And I guess we are waiting for FDA approval. Once that is done if done, and BMSN develops a marketed bio technology. This will give the company more money and possibly more connections thus they may be able to further develop into something possibly great in reference to stem cell technologies.
Who is BMSN competitors? And is there any specific technology that may be of competition with BMSN's technology that may develop from the patents?
What other patents are there to treat the same disease BMSN that BMSN is working on treating via the patents BMSN has acquired or whatever.
Won't BMSN have a lot going for it if FDA approves and they finally develop a there Bio Technology Product?
I do not support Embryonic Stem cells and as far as I know BMSN does not have intention to utilize Embryonic Stem Cells.